MYC Drives Progression of Small Cell Lung Cancer to a Variant Neuroendocrine Subtype with Vulnerability to Aurora Kinase Inhibition

Gürkan Mollaoglu(University of Utah), Matthew R. Guthrie(University of Utah), Stefanie Böhm(University of Cologne), Johannes Brägelmann(University of Cologne), İsmail Can(University of Utah), Paul M. Ballieu(University of Utah), Annika Marx(University of Cologne), Julie George(University of Cologne), Christine Heinen(University of Cologne), Milind D. Chalishazar(University of Utah), Haixia Cheng(University of Utah), Abbie S. Ireland(University of Utah), Kendall E. Denning(University of Utah), Anandaroop Mukhopadhyay(University of Utah), Jeffery M. Vahrenkamp(University of Utah), Kristofer C. Berrett(University of Utah), Timothy L. Mosbruger(Huntsman Cancer Institute), Jun Wang(Sanford Burnham Prebys Medical Discovery Institute), Jessica Kohan(University of Utah), Mohamed E. Salama(University of Utah), Benjamin L. Witt(University of Utah), Martin Peifer(University of Cologne), Roman K. Thomas(German Cancer Research Center), Jason Gertz(University of Utah), Jane E. Johnson(The University of Texas Southwestern Medical Center), Adi F. Gazdar(Southwestern Medical Center), Robert J. Wechsler‐Reya(Sanford Burnham Prebys Medical Discovery Institute), Martin L. Sos(University of Cologne), Trudy G. Oliver(University of Utah)
Cancer Cell
January 12, 2017
Cited by 605

Abstract


Related Papers

No related papers found

Powered by citation graph analysis